HANNAH KATZ: Open Payments
NPI 1356939201 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,646 in 85 payments from 24 companies in 2025. Trend: 2023 $697 · 2024 $1,178 · 2025 $3,646
Food & beverage: $2,843Travel & lodging: $803
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 7 | $1,252 |
| E.R. Squibb & Sons, L.L.C. | 15 | $424 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $375 |
| HEARTFLOW, INC. | 4 | $303 |
| Amgen Inc. | 6 | $165 |
| Novartis Pharmaceuticals Corporation | 9 | $154 |
| ABIOMED | 3 | $130 |
| AltaThera Pharmaceuticals LLC | 1 | $129 |
| Abbott Laboratories | 1 | $125 |
| BridgeBio Pharma, Inc. | 4 | $111 |
Products named: WATCHMAN Access System, Kerendia, FFRct, CAMZYOS, REPATHA, LEQVIO, Sotalol Hydrochloride, TRICLIP.
Industry payments across NE — which companies pay providers there.
